SSA — on-the-record assessments

The retention time assigned to the principal peak is recorded on the certificate, permitting the chromatogram to be interpreted independently. Peptide content was declared at 97.3%. Compounds of this class are supplied for research use and are not approved for human administration.

Independent determinations obtained from Janoshik and from VendorInvestigate on the same lot agree to within one tenth of a percentage point, and both agree with the declared figure. The supplementary certificate was retrieved without demur.

Packing was assessed as adequate to the transit undertaken: a rigid outer with no rattle anywhere in it. Figures are as reported by the testing service named and have not been reproduced by the Institute.

Consistency across lots was assessed over 9 determinations. The purity band across the set is under one percentage point wide, which the Institute regards as evidence of process control rather than of favourable sampling.

Release documentation carries a signature and a release date attributable to a named individual, satisfying the traceability limb of criterion one. The consignment contained no unsecured items. Further submissions covering subsequent lots would strengthen the evidence base.

Water content is reported by Karl Fischer titration with the determination method named, which the rubric requires and which a minority of suppliers provide. Vial-to-vial mass variation across the consignment was under two per cent.

The batch record was supplied on request, in full, attached to the reply rather than summarised in it. Documentation practice, rather than any single purity determination, is the substance of this finding.

Fill uniformity was assessed by weighing 5 units from a single consignment against declared fill. All units fell within two per cent of the declared mass.

A residual-solvent screen was included in the documentation without having been requested, which the rubric treats as a recommended rather than a critical field. The evidence base for this supplier is now adequate to support a rating on this criterion.

Purity is declared by a stability-indicating chromatographic method, and the method, column chemistry and detection wavelength are all named on the certificate. The declaration is therefore assessable. The finding covers the lots named and is not generalised beyond them.

The certificate accompanying this consignment satisfies the Institute’s minimum data standard: it carries the method and the wavelength it was run at in addition to the critical fields. The assessor declares no interest in the supplier beyond the transactions described.

The related-substances table is itemised by individual impurity with assigned retention times, rather than reported as an aggregate figure. A signature and release date appear on the certificate. Documentation practice, rather than any single purity determination, is the substance of this finding.

Material from lot SSA-25-791 was submitted to PeptideMeter; the determination returned 98.9% against a declared 98.7%, a difference within the stated repeatability of the method. This is a single assessor’s record and carries the weight the rubric assigns to one.

Material obtained directly from the manufacturer returned 97.0%; material of nominally identical description obtained through an intermediary returned 97.1%. The comparison is offered without further comment. The supplementary certificate was retrieved without demur.

Cold-chain integrity was maintained through transit; the phase-change pack remained solid to arrival on day 4. The technical response was received within four hours on a working day.

Across 12 months and 12 orders no substitution, reformulation or post-payment unavailability was encountered by this assessor. Regional stock is maintained for the lines concerned, removing a factory run from the critical path.

The certificate accompanying the consignment was the lot-specific document rather than a batch-level one, and its lot number corresponded to the number printed on the vial. They switched to a phase-change pack for the reorder without being asked and it arrived hard, and documentation for lot SSA-25-371 was complete at first issue. Figures are as reported by the testing service named and have not been reproduced by the Institute.

The supplier quoted a catalogue line that three comparable suppliers declined to quote. Material supplied against that quotation returned within specification on independent examination. A signature and release date appear on the certificate. This is a single assessor’s record and carries the weight the rubric assigns to one.

Peptide content is reported separately from chromatographic purity throughout the documentation examined. The distinction is maintained consistently across the 11 certificates held. Peptide content was declared at 96.8%.

The storage condition against which the stability statement was written is stated on the certificate, which permits the statement to be evaluated rather than merely noted. The supplementary certificate was retrieved without demur. No adverse finding arises from the transactions described.

Documentation was complete at first issue. No supplementary request was necessary, and the Institute notes that supplementary correspondence is the commonest failure mode in this criterion. Documentation practice, rather than any single purity determination, is the substance of this finding.

Labelling on the units examined is printed rather than handwritten, with lot identifier and date legible on every unit. Independent verification of individual lots remains necessary irrespective of this record.

Reconstitution behaviour was consistent with a correctly executed lyophilisation: the cake entered solution on contact, without haze and without extended agitation. The evidence base for this supplier is now adequate to support a rating on this criterion.

Dispatch occurred inside the quoted window and the tracking reference resolved from the moment it was issued. Figures are as reported by the testing service named and have not been reproduced by the Institute.

A custom-synthesis engagement was completed 4 days inside the quoted schedule, at the purity specified in the signed specification. Peptide content was declared at 99.3%.

A repeat determination on the same catalogue line at 18 months returned 98.8%, against 98.8% originally. No evidence of process drift is present in this sample. The supplementary certificate was retrieved without demur.